 limit durat remiss insulin depend children recent overt type low-dos cyclosporin preliminari data group cyclosporin induc frequent remiss insulin depend group insulin-depend type diabet children onset clinic manifest diabet analysi respons group patient initi studi observ remiss patient associ durat symptom sever hyperglycemia incid ketoacidosi plasma c-peptid concentr remiss follow-up period mean SE durat day day paramet durat remiss mean level cyclosporin first mo durat prediagnost polyuria unabl end remiss variat cyclosporin regimen titer autoantibodi progress beta-cel failur euglycem clamp techniqu insulin sensit time patient insulin mo patient remiss insulin depend glycem control insulin dosag c-peptid level two- nonremiss patient four- histor control subject cyclosporin regimen observ period serum creatinin unchang kidney biopsi mo treatment normal limit